These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36350405)

  • 21. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.
    Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD
    Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of the efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib versus methotrexate for disease-modifying antirheumatic drug-naïve patients with rheumatoid arthritis.
    Sung YK; Lee YH
    Z Rheumatol; 2021 Nov; 80(9):889-898. PubMed ID: 32970188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review].
    Bulanov NM; Moiseev SV
    Ter Arkh; 2023 Dec; 95(12):625329. PubMed ID: 38158941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade.
    Shenoy SV; Nagaraju SP; Bhojaraja MV; Prabhu RA; Rangaswamy D; Rao IR
    Nephrology (Carlton); 2021 Nov; 26(11):858-871. PubMed ID: 34176194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.
    Friedman MA; Curtis JR; Winthrop KL
    Ann Rheum Dis; 2021 Oct; 80(10):1255-1265. PubMed ID: 34493491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs.
    Lee YH; Song GG
    Z Rheumatol; 2021 May; 80(4):379-392. PubMed ID: 32367211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis.
    Rathore U; Thakare DR; Patro P; Agarwal V; Sharma A; Misra DP
    Clin Rheumatol; 2022 Jan; 41(1):33-44. PubMed ID: 34729652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review.
    Mori S; Ogata F; Tsunoda R
    Clin Rheumatol; 2021 Nov; 40(11):4457-4471. PubMed ID: 34554329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.
    Tong L; Adler S
    Postgrad Med; 2018 May; 130(4):381-393. PubMed ID: 29667921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal aging: risk factors and nephroprotection].
    Daroux M; Gaxatte C; Puisieux F; Corman B; Boulanger E
    Presse Med; 2009 Nov; 38(11):1667-79. PubMed ID: 19303736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biologics and further new drugs for rheumatic diseases since 2000].
    Krüger K
    Orthopade; 2018 Nov; 47(11):906-911. PubMed ID: 30280235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
    Górriz JL; Nieto J; Navarro-González JF; Molina P; Martínez-Castelao A; Pallardó LM
    J Clin Med; 2015 Oct; 4(10):1866-89. PubMed ID: 26512703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of MTX in the elderly and in patients with compromised renal function.
    Morgacheva O; Furst DE
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S85-94. PubMed ID: 21044439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphoma in rheumatic diseases].
    Rubbert-Roth A; Bittenbring JT; Assmann G
    Z Rheumatol; 2017 Oct; 76(Suppl 2):46-56. PubMed ID: 29330755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic measures in proteinuric nephropathy.
    Praga M
    Kidney Int Suppl; 2005 Dec; (99):S137-41. PubMed ID: 16336567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel therapeutic agents for the treatment of diabetic kidney disease.
    Hartman RE; Rao PSS; Churchwell MD; Lewis SJ
    Expert Opin Investig Drugs; 2020 Nov; 29(11):1277-1293. PubMed ID: 32799584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.
    Scheen AJ
    Drugs; 2015 Jan; 75(1):33-59. PubMed ID: 25488697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal and Cardiac Implications of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors: The State of the Science.
    Cruz JE; Ahuja T; Bridgeman MB
    Ann Pharmacother; 2018 Dec; 52(12):1238-1249. PubMed ID: 29911393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity-Related Glomerulopathy: Clinical Management.
    Herman-Edelstein M; Weinstein T; Chagnac A
    Semin Nephrol; 2021 Jul; 41(4):358-370. PubMed ID: 34715965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.